Antibacterial Drug Development

Expert Meetings

Overview

Increasing bacterial resistance coupled with decreasing research on new antibacterial drugs is creating a crisis that could disproportionately impact our most vulnerable populations, including children and the seriously ill.  

CTTI has created approaches for streamlining antibacterial drug development that will help you design clinical trials that better assess the efficacy and safety of new antibacterial drugs and inform clinical trial planning, recruitment, enrollment, and feasibility. Use CTTI’s recommendations and resources to help combat this complex public health concern.

Projects

ABDD HABP/VABP STUDIES

Learn about CTTI’s prospective, multi-center, observational study of the risk factors for HABP/VABP.

ABDD PEDS TRIALS

Design pediatric antibacterial trials that ensure adequate enrollment, decrease the burden on sites and families, and increase engagement with healthcare providers.

ABDD STREAMLINING HABP/VABP TRIALS

Streamline protocol elements and data collection in HABP/VABP trials to increase enrollment, reduce trial complexity, and optimize operational efficiency.

ABDD UNMET NEED

Read about CTTI’s research findings on patient and physician perspectives and considerations as it relates to using antibacterial drugs developed through streamlined development processes.

News

Case Study